Cargando…
An open-label, single-arm phase 2 trial of valemetostat for relapsed or refractory adult T-cell leukemia/lymphoma
Adult T-cell leukemia/lymphoma (ATL) is an aggressive non-Hodgkin lymphoma with poor prognosis and few treatment options for patients with relapsed, recurrent, or refractory disease. We evaluated the efficacy and safety of valemetostat, a potent enhancer of zeste homolog 2 (EZH2) and EZH1 inhibitor,...
Autores principales: | Izutsu, Koji, Makita, Shinichi, Nosaka, Kisato, Yoshimitsu, Makoto, Utsunomiya, Atae, Kusumoto, Shigeru, Morishima, Satoko, Tsukasaki, Kunihiro, Kawamata, Toyotaka, Ono, Takaaki, Rai, Shinya, Katsuya, Hiroo, Ishikawa, Jun, Yamada, Hironori, Kato, Kazunobu, Tachibana, Masaya, Kakurai, Yasuyuki, Adachi, Nobuaki, Tobinai, Kensei, Yonekura, Kentaro, Ishitsuka, Kenji |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651775/ https://www.ncbi.nlm.nih.gov/pubmed/36150143 http://dx.doi.org/10.1182/blood.2022016862 |
Ejemplares similares
-
Prognosis of patients with adult T‐cell leukemia/lymphoma in Japan: A nationwide hospital‐based study
por: Imaizumi, Yoshitaka, et al.
Publicado: (2020) -
Valemetostat Tosilate: First Approval
por: Keam, Susan J.
Publicado: (2022) -
Epidemiological and clinical features of adult T‐cell leukemia–lymphoma in Japan, 2010–2011: A nationwide survey
por: Nosaka, Kisato, et al.
Publicado: (2017) -
Epidemiology of adult T‐cell leukemia‐lymphoma in Japan: An updated analysis, 2012‐2013
por: Ito, Shigeki, et al.
Publicado: (2021) -
Correction to: Valemetostat Tosilate: First Approval
por: Keam, Susan J.
Publicado: (2022)